A new CRISPR enzyme has been developed that could revolutionize the way we treat genetic diseases in humans. The enzyme, called CRISPR-CasX, was discovered by researchers at the University of California, San Francisco and is the first of its kind to be able to edit DNA without the need of pre-existing genetic material. This could potentially mean that doctors could use CRISPR-CasX to directly edit the DNA of a patient and potentially treat a range of genetic diseases. The new enzyme could also be used to create customized treatments for individual patients, allowing for more personalized care. The possibilities for this new technology are truly exciting and could lead to breakthroughs in treating a range of genetic disorders.

Read Full Article Here

source: Phys.org